€12M Series A Financing to Develop Novel Immuno-Virotherapies Against Cancer
Abalos Therapeutics announced a EUR 12 million Series A financing round establishing its operations and leadership. The Company’s objective is to develop new immuno-oncology therapeutics based on a specific arenavirus strain that preferentially infects and proliferates in cancer cells gener ... > more